Douros A - Search Results

1

RE: Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.

Khosrow-Khavar F, Kurteva S, Douros A. Khosrow-Khavar F, et al. Among authors: douros a. J Natl Cancer Inst. 2019 Oct 1;111(10):1107-1108. doi: 10.1093/jnci/djz066. J Natl Cancer Inst. 2019. PMID: 31020327 Free PMC article. No abstract available.

2

Opioids and the Risk of Infection: A Critical Appraisal of the Pharmacologic and Clinical Evidence.

Khosrow-Khavar F, Kurteva S, Cui Y, Filion KB, Douros A. Khosrow-Khavar F, et al. Among authors: douros a. Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):565-575. doi: 10.1080/17425255.2019.1634053. Epub 2019 Jun 27. Expert Opin Drug Metab Toxicol. 2019. PMID: 31211608 Review.

3

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L. Douros A, et al. Diabetes Care. 2018 Nov;41(11):2330-2338. doi: 10.2337/dc17-2280. Epub 2018 Aug 27. Diabetes Care. 2018. PMID: 30150234

4

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes.

Douros A, Rouette J, Yin H, Yu OHY, Filion KB, Azoulay L. Douros A, et al. Diabetes Care. 2019 Aug;42(8):1496-1503. doi: 10.2337/dc19-0409. Epub 2019 Jun 10. Diabetes Care. 2019. PMID: 31182489

5

Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.

Filion KB, Douros A, Azoulay L, Yin H, Yu OH, Suissa S. Filion KB, et al. Among authors: douros a. Br J Clin Pharmacol. 2019 Oct;85(10):2378-2389. doi: 10.1111/bcp.14056. Epub 2019 Jul 31. Br J Clin Pharmacol. 2019. PMID: 31276600 Free PMC article.

6

Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.

Ou LB, Moriello C, Douros A, Filion KB. Ou LB, et al. Among authors: douros a. Br J Clin Pharmacol. 2021 Oct;87(10):3649-3658. doi: 10.1111/bcp.14737. Epub 2021 Mar 4. Br J Clin Pharmacol. 2021. PMID: 33439512 Free article. Review.

7

The modifying effects of adiposity on the cardiovascular safety of sulphonylureas.

Suissa K, Schneeweiss S, Douros A, Filion KB, Yin H, Patorno E, Azoulay L. Suissa K, et al. Among authors: douros a. Diabetes Obes Metab. 2021 Nov;23(11):2502-2512. doi: 10.1111/dom.14494. Epub 2021 Aug 3. Diabetes Obes Metab. 2021. PMID: 34251086

8

Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease.

Douros A, Cui Y, Platt RW, Filion KB, Sebastiani G, Renoux C. Douros A, et al. Br J Clin Pharmacol. 2022 Mar;88(3):994-1009. doi: 10.1111/bcp.15046. Epub 2021 Sep 12. Br J Clin Pharmacol. 2022. PMID: 34409636 Free article.

9

5-α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population-based cohort study.

Ayele HT, Douros A, Filion KB. Ayele HT, et al. Among authors: douros a. Br J Clin Pharmacol. 2022 Aug;88(8):3771-3781. doi: 10.1111/bcp.15317. Epub 2022 Apr 3. Br J Clin Pharmacol. 2022. PMID: 35301747 Free article.

10

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S. Douros A, et al. BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693. BMJ. 2018. PMID: 30021781 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters